Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christopher McCarley

Physician Assistant, Surgical Tupelo, MS Physician Assistant

NPI 1497768675 CMS profile 11246671

830 S Gloster St, Nmmc East Tower 3Rd Floor, Tupelo, MS 38801

Open in the dashboard

General payments

$3,179

95 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher McCarley of Tupelo, MS is reported in the CMS Open Payments database as having received $3,179 across 95 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $622 25
2024 General $1,043 31
2023 General $1,144 24
2022 General $232 9
2021 General $138 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher McCarley
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Christopher McCarley were reported at $622. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Christopher McCarley Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $138 $111 $36–$285 $132
2022 $232 $126 $44–$350 $149
2023 $1,144 $137 $47–$355 $160
2024 $1,043 $146 $49–$384 $164
2025 $622 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Intuitive Surgical, Inc. $1,182 9 payments
  2. Edwards Lifesciences Corporation $280 11 payments
  3. Atricure, Inc. $270 13 payments
  4. Silk Road Medical, Inc. $201 8 payments
  5. Medtronic, Inc. $170 7 payments
  6. LeMaitre Vascular, Inc. $161 8 payments
  7. Boston Scientific Corporation $87 4 payments
  8. CryoLife, Inc. $73 2 payments
  9. W. L. Gore & Associates, Inc. $65 3 payments
  10. Bard Peripheral Vascular, Inc. $58 4 payments
  11. Other $632 26 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,088 89 payments
  2. Travel and Lodging $1,091 6 payments
Products named General payments · program years 2021–2025
  1. Da Vinci Surgical System $1,182 9 payments
  2. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $201 8 payments
  3. ENROUTE Transcarotid Stent $201 8 payments
  4. SYNERGY ABLATION SYSTEM $167 8 payments
  5. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $141 6 payments
  6. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $141 6 payments
  7. COREVALVE EVOLUT R $135 6 payments
  8. EDWARDS INTUITY ELITE VALVE SYSTEM $120 5 payments
  9. ATRICLIP LAA EXCLUSION SYSTEM $113 5 payments
  10. AMDS-Ascyrus Medical $73 2 payments
  11. Other $1,393 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

60

Median for Physician Assistant: 241

Drug cost

$407

Median for Physician Assistant: $4,110

Branded share of claims

75%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 32 $227
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $141
Metoprolol Succinate Generic 15 $38

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$13,855

Medicare's payments for the services billed

Medicare patients

59

Average age 73

Services billed

110

25 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Diabetes 59%
Arthritis 54%
Chronic kidney disease 47%
Atrial fibrillation 46%
Heart failure 39%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

95 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record